Torys: Triumvira Immunologics' Partnership with Merck to Evaluate TAC01-HER2 Cell Therapy

Torys LLP acted as counsel to Triumvira Immunologics on the collaboration with Merck. On January 5, 2023, Triumvira Immunologics, Inc. ("Triumvira") announced a clinical trial collaboration [...]